SXTPW60 DEGREES PHARMACEUTICALS, INC.同业对比
60 DEGREES PHARMACEUTICALS, INC. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SXTPW本股 | $163546#8 | — | 0.0x#7 | 0.2x#4 | 65.5%#2 | 7.3%#5 | -771.6%#5 | -152.5%#8 | -167.4%#2 | 5#1 | — | — |
| ATXI | $1M#3 | — | 1.1x#11 | 1.0x#5 | — | 75.0%#1 | -219.6%#3 | -242.8%#10 | — | — | — | — |
| PTIX | $1M#4 | — | — | — | — | -10.5%#7 | — | — | — | — | — | — |
| ELAB | $4M#2 | — | 0.3x#10 | 7.1x#10 | — | -24.0%#9 | -1304.4%#7 | -61.5%#4 | — | — | — | — |
| VBIO | $976571#5 | — | 0.1x#9 | 1.3x#6 | -33.7%#5 | -57.0%#11 | -1012.6%#6 | -80.3%#6 | — | — | — | — |
| KTTAW | $895507#6 | — | 0.0x#6 | 1.8x#7 | 3130.4%#1 | -46.9%#10 | -4286.7%#8 | -37.3%#3 | — | — | — | — |
| BFRIW | $448117#7 | — | 0.1x#8 | 0.0x#3 | 11.7%#3 | 40.7%#3 | -27.2%#2 | -173.6%#9 | -23159.2%#4 | — | — | — |
| SBFMW | $160691#9 | 0.0x#4 | 0.0x#3 | 0.0x#2 | 4.1%#4 | -16.4%#8 | -17.2%#1 | -27.8%#1 | -162.1%#1 | — | — | — |
| ASBPW | $29790#12 | 0.0x#3 | 0.0x#4 | 4.8x#9 | — | -1768.9%#14 | -312016.9%#9 | -632.8%#11 | — | — | — | — |
| DRMAW | $72399#10 | — | 0.0x#5 | — | — | 38.5%#4 | — | -117.9%#7 | — | — | — | — |
| CDTTW | $42282#11 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#13 | — | -37.2%#2 | — | — | — | — |
| REVBW | $24232#13 | — | 0.0x#2 | — | — | 40.7%#2 | — | -68.6%#5 | — | — | — | — |
| CELUW | $11578#14 | — | — | 0.0x#1 | -51.0%#6 | -58.4%#12 | -230.9%#4 | — | -398.1%#3 | — | — | — |
| ADTX | $7588#15 | 0.0x#1 | — | 2.4x#8 | -97.6%#7 | -6.8%#6 | -612542.2%#10 | — | — | — | — | — |
| AAPG | $6.7B#1 | — | — | — | — | — | — | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议